Little Innovation In US OTC Switches For 20 Years, ACNU Won't Remove Impediments – Study

Of 45 switches since 2002, three added an indication to OTC market and three were “an exceptional innovation” offering “a genuinely novel OTC product, providing a new to OTC active pharmaceutical ingredient, pharmacological class, and indication,” Haleon researchers found.